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DISCUSSION
LVRS has been shown to improve the QOL, respiratory
physiology, and survival in highly selected patients.1,2 Sig-
nificant cardiac comorbidity is generally considered a contra-
indication to LVRS. Untreated symptomatic severe aortic
stenosis, however, is associated with a poor prognosis.3 In
contrast, patients who undergo successful AVR for symp-
tomatic aortic stenosis experience a significant survival
benefit.3 Appropriate case selection allied with careful perio-
perative planning in this case resulted in QOL, functional,
pulmonary, and prognostic benefits. A multidisciplinary
approach was essential in providing an optimal outcome.
A skilled anesthetist was required to ensure proper place-
ment of the epidural catheter and double-lumen endotra-
cheal tube and intraoperative management of the patient.
An error in any of these areas could potentially lead to
severe consequences. The epidural catheter was placed 4
hours before scheduled surgery, as this strategy has been
shown to be safe despite full anticoagulation for CPB.4 A
satisfactory postoperative thoracic epidural analgesia con-
tributed to the patient’s good compliance with physiother-
apy and breathing exercises, thereby reducing the risks of
postoperative sputum retention and chest infection. Careful
anesthetic and intensive care management allowed for main-
tenance of cardiorespiratory stability and a successful
planned early extubation, thereby minimizing the risks asso-
ciated with mechanical ventilation. Daily medical manage-
ment by the chest physicians in the perioperative period
also ensured that the patient received optimal medical ther-
apy for her emphysema.
The decision to perform the AVR first followed by rever-
sal of anticoagulation prior to LVRS ensured that there was
normal hemostasis during LVRS to minimize the risk of pul-
monary hemorrhage. We also found it useful to divide the
pleural adhesions while both lungs were deflated during
CPB. We felt that it was important to achieve satisfactory
cardiorespiratory stability and hemostasis before proceeding
with the LVRS. A bioprosthetic valve was placed as the pa-
tient did not want anticoagulation associated with a mechan-
ical valve. Although a tissue valve is not as durable as
a mechanical valve, patients with an FEV1<1 L have a mor-
tality rate of approximately 10% per year. It is probable that
a bioprosthetic valve may outlast the patient’s life expec-
tancy under these circumstances.5
In summary, careful perioperative planning and multidis-
ciplinary strategies ensured a successful concomitant LVRS
and AVR with satisfactory clinical outcome and marked
benefit for the patient.
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doi:10.1016/j.jtcvs.2008.09.0521552 The Journal of Thoracic and Cardiovascular SurCoronary artery disease (CAD) is prevalent in patients
with severe emphysema who are being considered for
lung volume reduction surgery (LVRS).1 The National
Emphysema Treatment Trial excludes patients with a va-
riety of cardiovascular risk factors from undergoing
LVRS, as do many surgeons who perform the procedure
outside the trial.2 We describe a multidisciplinary ap-
proach that led to successful combined LVRS and coro-
nary artery bypass grafting (CABG) surgery and discuss
the implications and advantages relating to this combined
approach.gery c June 2009
Brief CommunicationsCLINICAL SUMMARY
A 53-year-old man was referred for LVRS. He had been
considered unsuitable for LVRS at another institution be-
cause of the presence of an occluded left anterior descending
coronary artery that was not amenable to percutaneous inter-
vention. He had poor pulmonary function caused by bilateral
upper lobe severe emphysema (Table 1). He had stopped
smoking 6 years previously and was motivated to improve.
His left ventricular function was preserved. He consented to
a combined bilateral LVRS and CABG. A multidisciplinary
approach previously described was adopted.3
A thoracic epidural catheter was placed 4 hours before the
scheduled operation to minimize the risk of epidural hema-
toma related to the impending systemic anticoagulation re-
quired for cardiopulmonary bypass (CPB) for CABG. The
operation was performed through a median sternotomy.
The left internal thoracic artery was used to graft the left an-
terior descending coronary artery. After CABG and during
CPB, pleural adhesions on the deflated lungs were divided
by using electrocautery. The patient was then weaned off
CPB, and the anticoagulation was fully reversed. After sat-
isfactory cardiorespiratory stability and hemostasis, the
LVRS proceeded with the left followed by the right lung
using single-lung ventilation. Approximately 30% of each
lung was removed by using a stapler buttressed with bovine
pericardium. An early extubation, adequate analgesia, and
regular physiotherapy were ensured during the postoperative
period. The chest drains were removed on postoperative day
5, and the patient was discharged home on day 9.At 4months,
he had a left basal pneumothorax that was successfully treated
with chest tube drainage. At 6 months’ follow-up, he had
a marked improvement and had returned to full-time work
(Table 1).
DISCUSSION
Most patients with end-stage emphysema have a history
of smoking and are therefore at increased risk for CAD.Fifteen percent of the patients who were suitable to undergo
LVRS were found to have coexisting CAD in a report by
Turnheer and colleagues.1 Because dyspnea is often multi-
factorial, some patients will have severe and disabling symp-
toms from a combination of cardiac and pulmonary diseases.
The National Emphysema Treatment Trial has shown that in
highly selected patients, LVRS offer symptomatic and prog-
nostic benefits.4 Although some candidates for LVRS have
CADs that are amenable to percutaneous intervention,
others have diseases that are not appropriate for such inter-
vention and require CABG. However, these patients are
often turned down for LVRS because significant cardiac
comorbidity is generally considered a contraindication for
LVRS. Appropriate case selection and a multidisciplinary
approach have resulted in a successful combined cardiac
procedure and LVRS in this case. The fact that the cardiac
operation can be performed safely in conjunction with
LVRS in highly selected patients has implications for 2
groups of patients.
The first groups of patients includes those who are denied
an LVRS on the basis of concomitant cardiac diseases, such
as valvular disease or CAD, that would either increase the
risk of LVRS or limit their potential for full postoperative re-
covery. These patients might be considered for a combined
operation.
The second group of patients consists of those who are de-
nied a cardiac operation because of a perceived excessive
operative risk caused by concomitant severe emphysema.
In this group of patients, evaluation of suitability for
LVRS could indicate that a combined operation might not
only be feasible but might actually reduce the risks of the
cardiac procedure by decreasing postoperative pulmonary
complications.
There are a number of advantages in performing a com-
bined operation: (1) improved patient convenience, such
as only requiring a single hospital admission and operation;
(2) reduced costs; and (3) avoidance of difficulties that are
associated with performing the operations as a stagedTABLE 1. Symptoms and pulmonary function measurements before and after surgical intervention
Preoperative baseline 6-mo Postoperative Improvement (%)
Modified Medical Research Council Dyspnea Scale (degree of dyspnea) Category 4 (severe) Category 1 (slight)
SF-36 Physical Function Score 30 70
Normal full-time work (office based with intermittent travelling) Unable Back to normal full-time work
FEV1 (% predicted) 1.40 L (45%) 2.60 L (84%) 85
FER (% predicted) 42 (52%) 73 (90%) 72
TLCO mmol CO $ kPa1 $ min1 (% predicted) 3.26 (36%) 3.68 (41%) 4
KCO (% predicted) 0.71 (49%) 0.85 (59%) 14
FRC (% predicted) 4.81 L (147%) 4.13 L (126%) 16
RV (% predicted) 4.43 L (212%) 3.22 L (153%) 38
RV/TLC 65% 47% 27
6-min Walk 195 m 360 m 84
Oxygen saturation on room air 90% 98% 9
SF-36, Short-Form 36; FEV1, forced expiratory volume in 1 second; FER, forced expiratory ratio; TLCO, transfer factor of carbon monoxide; KCO, carbon monoxide transfer
coefficient; FRC, functional residual capacity; RV, residual volume; TLC, total lung capacity.
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Brief Communicationsprocedure (eg, the risks of redo sternotomy to perform the
second procedure [LVRS]). Even if one is performing
a video-assisted thoracoscopic LVRS after CABG, there
are likely to be adhesions relating to previous opening of
the pleura to harvest the internal thoracic artery for use as
a conduit. Pleural adhesions can make LVRS difficult and
are associated with increased morbidity.
In summary, a multidisciplinary team approach has al-
lowed this patient to undergo a successful combined
LVRS and CABG. The ability to safely carry out a combined
cardiac procedure and LVRS has important implications and
advantages.Off-pump revascularization with the
arteries in a 3-year-old child with Ka
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Kawasaki syndrome is a generalized vasculitis of unknown
origin. Giant coronary artery aneurysms develop in 0.27%
of cases.1 We present the case of a 3-year-old boy with
Kawasaki disease with giant coronary artery aneurysms af-
ter myocardial infarction. The patient underwent success-
ful revascularization with both internal thoracic arteries
(ITAs).
CLINICAL SUMMARY
A 31/2 -old-boy had a history of acute Kawasaki disease in
September 2003 at the age of 4 months, with giant coronary
artery aneurysms (Figures 1 and 2) after standard treatment
in the acute stage. During 32 months of follow-up he re-
ceived treatment with an oral anticoagulant and aspirin, re-
maining in good general condition with a normal ejection
fraction (EF) on transthoracic echocardiography (TTE).
In April 2006 after a varicella infection, his mother no-
ticed slight cyanosis around the mouth, pale skin, and weak-
ness. Physical examination revealed tachycardia, a third
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heart sound, and a systolic murmur at the apex. On the elec-
trocardiogram, new pathologic Q waves were seen in leads
II, III, and aVF.Myocardial damage markers were in the nor-
mal range. TTE revealed severe left ventricular dysfunction.
The apex and the anterolateral part of the left ventricle were
akinetic. This was also confirmed by thallium scintigraphy.
FIGURE 1. Frontal projection of selective LCA injection showing the
large aneurysm involving left main and proximal aspects of LAD and cir-
cumflex coronary arteries—acute stage.
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